---
figid: PMC7779530__fcell-08-607483-g002
figtitle: TGFB signaling
organisms:
- Oryza sativa
- Lareunionomyces loeiensis
- Malus domestica
- Panax ginseng
- Curcuma longa
- Scutellaria baicalensis
- Tripterygium wilfordii
- Silybum marianum
- Oldenlandia diffusa
- Panax japonicus
- Ribes diacanthum
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Sus scrofa
- Homo sapiens
- gut metagenome
- Mycobacterium tuberculosis variant bovis BCG
- Ambystoma mexicanum
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Sus scrofa
- Oryctolagus cuniculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7779530
filename: fcell-08-607483-g002.jpg
figlink: pmc/articles/PMC7779530/figure/F2/
number: F2
caption: Schematic diagram of the TGF-β signaling. (Left) The canonical (Smad) signaling
  involves the TGF-β-Receptor, which phosphorylates R-Smads (Smad2 and 3). Smad2/3
  bind to Smad4, translocate to the nucleus and activate, among others, genes that
  directly regulate EMT. Smad7, negatively controls the TGF-β signaling by inhibiting
  R-Smads phosphorylation, by competing directly with Smad2 and 3 for the TGF-β-Receptor
  binding. (Right) The non-canonical (non-Smad) TGF-β signaling pathway starts from
  the TGF-β-Receptor and mediates the induction of EMT through the activation of several
  kinases.
papertitle: The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target
  in Fibrotic Disorders.
reftext: Jacopo Di Gregorio, et al. Front Cell Dev Biol. 2020;8:607483.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9521617
figid_alias: PMC7779530__F2
figtype: Figure
redirect_from: /figures/PMC7779530__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7779530__fcell-08-607483-g002.html
  '@type': Dataset
  description: Schematic diagram of the TGF-β signaling. (Left) The canonical (Smad)
    signaling involves the TGF-β-Receptor, which phosphorylates R-Smads (Smad2 and
    3). Smad2/3 bind to Smad4, translocate to the nucleus and activate, among others,
    genes that directly regulate EMT. Smad7, negatively controls the TGF-β signaling
    by inhibiting R-Smads phosphorylation, by competing directly with Smad2 and 3
    for the TGF-β-Receptor binding. (Right) The non-canonical (non-Smad) TGF-β signaling
    pathway starts from the TGF-β-Receptor and mediates the induction of EMT through
    the activation of several kinases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfbr3
  - Tgfbr2
  - Tgfbr1
  - Tgfb1
  - Ltbp1
  - Smad3
  - Smad4
  - Smad2
  - Smad7
  - Nr2c2
  - Map3k7
  - Akt1
  - Nfkb1
  - Ephb2
  - Mapk1
  - Mapk3
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Ilk
  - Twist1
  - Snai1
  - TGFBR2
  - TGFBR1
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD3
  - SMAD4
  - SMAD2
  - SMAD7
  - MAP3K7
  - NR2C2
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - EPHB2
  - MAPK1
  - MAPK3
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - ILK
  - TWIST1
  - SNAI1
  - Rela
  - Ephb1
  - dpp
  - gbb
  - put
  - mav
  - Med
  - Smox
  - Dad
  - Tak1
  - Akt
  - Dif
  - dl
  - Rel
  - Erk7
  - rl
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - twi
  - sna
  - smad3a
  - smad4a
  - smad4b
  - smad2
  - smad7
  - mapk3
  - mapk14a
  - mapk8b
  - ilk
---
